Red bar, you haven't provided any analysis at all of the...

Red bar, you haven't provided any analysis at all of the companies expansion and progress throughout AUS UK, and the Singapore approval. You must have been too focused on RAP. Remember that went to 50c, on the leadup of its US clinical trial results alone, and 0 expansion elsewhere. then the failed 1st round US trial.

Thought you were going to talk to PD and read his facial expressions to determine where to buy, and we remember as you stated, when you buy, you buy big. you dont play with pennies.

I do think the price is pretty hyped at the moment mind you.